MBABANE – The Mkhondvo-Ngwavuma Water Augmentation Programme (MNWAP) is set to serve as a case study for Eswatini’s Development and Application of Public-Private Partnership (PPP) toolkits.

The Tennessee Valley Authority has become a leading supporter of small modular reactors, helping developers derisk projects ...

President Netumbo Nandi-Ndaitwah has announced a five-year visa option for investors who are serious about doing business in Namibia.

IISc Bangalore invites applications for mid-year Ph.D. admissions in research and external registration programmes ...

Enigma Biomedical USA (EB USA) today announced that the Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for MK-6240 (florquinitau F-18), their Tau Positron Emission ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Health Canada has issued a Notice of Compliance ...

1. About lecanemab (generic name, brand name: LEQEMBI®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...

Tuesday's ceremonial groundbreaking for the redevelopment of Brownsville's Buena Vida neighborhood was more than 10 years in the making, according to Carla Mancha, CEO of the Housing Authority of the ...

Health Canada grants authorization for Leqembi to treat early Alzheimer’s disease: Stockholm Tuesday, October 28, 2025, 10:00 Hrs [IST] BioArctic AB’s (publ) partner Eisai ann ...

Viehbacher, “Biogen”) announced today that LEQEMBI ® IQLIK™, a subcutaneous autoinjector formulation of lecanemab (generic name), for the treatment of Alzheimer’s disease (AD) has been selected by ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts ...